Trials / Conditions / Exocrine Pancreatic Cancer
Exocrine Pancreatic Cancer
4 registered clinical trials studyying Exocrine Pancreatic Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | High Dose Omeprazole in Patients With Pancreatic Cancer NCT04930991 | University of Oklahoma | EARLY_Phase 1 |
| Recruiting | PATAKESS Protocol : Clinical and Biological Analysis of Exocrine Pancreatic Tumors NCT04011982 | Centre Leon Berard | — |
| Active Not Recruiting | Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors NCT03485209 | Seagen, a wholly owned subsidiary of Pfizer | Phase 2 |
| Completed | Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment NCT01020006 | Pharmacyclics LLC. | Phase 2 |